159 related articles for article (PubMed ID: 34420582)
1. Inhibition of hepatitis C virus by vitamin D.
Murayama A; Kato T
Vitam Horm; 2021; 117():227-238. PubMed ID: 34420582
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D derivatives inhibit hepatitis C virus production through the suppression of apolipoprotein.
Murayama A; Saitoh H; Takeuchi A; Yamada N; Matsumura T; Shiina M; Muramatsu M; Wakita T; Imawari M; Kato T
Antiviral Res; 2018 Dec; 160():55-63. PubMed ID: 30339849
[TBL] [Abstract][Full Text] [Related]
3. 25-Hydroxyvitamin D3 suppresses hepatitis C virus production.
Matsumura T; Kato T; Sugiyama N; Tasaka-Fujita M; Murayama A; Masaki T; Wakita T; Imawari M
Hepatology; 2012 Oct; 56(4):1231-9. PubMed ID: 22487892
[TBL] [Abstract][Full Text] [Related]
4. Randomized study comparing vitamin D3 and 1α-Hydroxyvitamin D3 in combination with pegylated interferon/ribavirin therapy for chronic hepatitis C.
Omori-Mizuno Y; Nakayama N; Inao M; Funyu J; Asabe S; Tomita K; Nishikawa K; Hosoda Y; Tanaka M; Hashimoto Y; Yakabi K; Koshima Y; Mochida S
J Gastroenterol Hepatol; 2015 Sep; 30(9):1384-90. PubMed ID: 25778685
[TBL] [Abstract][Full Text] [Related]
5. 1(OH) vitamin D3 supplementation improves the sensitivity of the immune-response during Peg-IFN/RBV therapy in chronic hepatitis C patients-case controlled trial.
Kondo Y; Kato T; Kimura O; Iwata T; Ninomiya M; Kakazu E; Miura M; Akahane T; Miyazaki Y; Kobayashi T; Ishii M; Kisara N; Sasaki K; Nakayama H; Igarashi T; Obara N; Ueno Y; Morosawa T; Shimosegawa T
PLoS One; 2013; 8(5):e63672. PubMed ID: 23717463
[TBL] [Abstract][Full Text] [Related]
6. Vitamin D-related gene polymorphism predict treatment response to pegylated interferon-based therapy in Thai chronic hepatitis C patients.
Thanapirom K; Suksawatamnuay S; Sukeepaisarnjaroen W; Tangkijvanich P; Treeprasertsuk S; Thaimai P; Wasitthankasem R; Poovorawan Y; Komolmit P
BMC Gastroenterol; 2017 Apr; 17(1):54. PubMed ID: 28415985
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes.
Gal-Tanamy M; Bachmetov L; Ravid A; Koren R; Erman A; Tur-Kaspa R; Zemel R
Hepatology; 2011 Nov; 54(5):1570-9. PubMed ID: 21793032
[TBL] [Abstract][Full Text] [Related]
8. Vitamin D Metabolites Inhibit Hepatitis C Virus and Modulate Cellular Gene Expression.
Gutierrez JA; Jones KA; Flores R; Singhania A; Woelk CH; Schooley RT; Wyles DL
J Virol Antivir Res; 2014 Oct; 3(3):. PubMed ID: 26594646
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy.
Lange CM; Bojunga J; Ramos-Lopez E; von Wagner M; Hassler A; Vermehren J; Herrmann E; Badenhoop K; Zeuzem S; Sarrazin C
J Hepatol; 2011 May; 54(5):887-93. PubMed ID: 21145801
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients.
Abu-Mouch S; Fireman Z; Jarchovsky J; Zeina AR; Assy N
World J Gastroenterol; 2011 Dec; 17(47):5184-90. PubMed ID: 22215943
[TBL] [Abstract][Full Text] [Related]
11. Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV-HCV co-infected patients with chronic hepatitis.
Terrier B; Carrat F; Geri G; Pol S; Piroth L; Halfon P; Poynard T; Souberbielle JC; Cacoub P
J Hepatol; 2011 Oct; 55(4):756-61. PubMed ID: 21334402
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: a systematic review and meta-analysis.
Kitson MT; Sarrazin C; Toniutto P; Eslick GD; Roberts SK
J Hepatol; 2014 Dec; 61(6):1247-52. PubMed ID: 25135863
[TBL] [Abstract][Full Text] [Related]
13. Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C.
Falleti E; Cmet S; Fabris C; Fattovich G; Cussigh A; Bitetto D; Ceriani E; Lenisa I; Dissegna D; Ieluzzi D; Rostello A; Pirisi M; Toniutto P
PLoS One; 2013; 8(11):e80764. PubMed ID: 24244713
[TBL] [Abstract][Full Text] [Related]
14. Low vitamin D levels are associated with impaired virologic response to PEGIFN + RBV therapy in HIV-hepatitis C virus coinfected patients.
Mandorfer M; Reiberger T; Payer BA; Ferlitsch A; Breitenecker F; Aichelburg MC; Obermayer-Pietsch B; Rieger A; Trauner M; Peck-Radosavljevic M;
AIDS; 2013 Jan; 27(2):227-32. PubMed ID: 23238552
[TBL] [Abstract][Full Text] [Related]
15. Effect of vitamin D supplementation on pegylated interferon/ribavirin therapy for chronic hepatitis C genotype 1b: a randomized controlled trial.
Yokoyama S; Takahashi S; Kawakami Y; Hayes CN; Kohno H; Kohno H; Tsuji K; Aisaka Y; Kira S; Yamashina K; Nonaka M; Moriya T; Kitamoto M; Aimitsu S; Nakanishi T; Kawakami H; Chayama K
J Viral Hepat; 2014 May; 21(5):348-56. PubMed ID: 24716637
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus markers in infection by hepatitis C virus: In the era of directly acting antivirals.
Coppola N; Pisaturo M; Zampino R; Macera M; Sagnelli C; Sagnelli E
World J Gastroenterol; 2015 Oct; 21(38):10749-59. PubMed ID: 26478667
[TBL] [Abstract][Full Text] [Related]
17. Therapy of chronic hepatitis C virus infection in the era of direct-acting and host-targeting antiviral agents.
Conteduca V; Sansonno D; Russi S; Pavone F; Dammacco F
J Infect; 2014 Jan; 68(1):1-20. PubMed ID: 24012819
[TBL] [Abstract][Full Text] [Related]
18. Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection.
Casey JL; Feld JJ; MacParland SA
Cells; 2019 Apr; 8(4):. PubMed ID: 30959825
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of vitamin D supplementation in combination with conventional antiviral therapy in patients with chronic hepatitis C infection: a meta-analysis of randomised controlled trials.
Kim HB; Myung SK; Lee YJ; Park BJ;
J Hum Nutr Diet; 2018 Apr; 31(2):168-177. PubMed ID: 28833855
[TBL] [Abstract][Full Text] [Related]
20. Vitamin D improves viral response in hepatitis C genotype 2-3 naïve patients.
Nimer A; Mouch A
World J Gastroenterol; 2012 Feb; 18(8):800-5. PubMed ID: 22371640
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
